Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02142 (Long intergenic non-protein coding RNA 2142) is a member of the long intergenic non-coding RNA (lincRNA) family. LincRNAs are a subset of long non-coding RNAs (lncRNAs), typically longer than 200 nucleotides and transcribed from regions that do not overlap annotated protein-coding genes[1][5][7]. LincRNAs, including LINC02142, are believed to regulate gene expression, chromatin architecture, and transcription, often with tissue specificity[1]. However, the specific biological role and disease relevance of LINC02142 remain uncharacterized; current knowledge is limited to its identification as an RNA gene without evidence for peptide/protein coding potential or therapeutic targeting[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2142 (LINC02142).